1. Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart
   Javad Garousi et al, 2022, Pharmaceutics CrossRef
2. Small Bispecific Affinity Proteins for Simultaneous Target Binding and Albumin-Associated Half-Life Extension
   Emma von Witting et al, 2021, Molecular Pharmaceutics CrossRef
3. Pseudomonas aeruginosa in Cancer Therapy: Current Knowledge, Challenges and Future Perspectives
   Zheng Pang et al, 2022, Frontiers in Oncology CrossRef
4. The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy
   Wen Yin et al, 2021, Pharmaceutics CrossRef
5. Effect of Inter-Domain Linker Composition on Biodistribution of ABD-Fused Affibody-Drug Conjugates Targeting HER2
   Tianqi Xu et al, 2022, Pharmaceutics CrossRef